News Focus
News Focus
icon url

ATLnsider

02/07/22 5:27 PM

#442056 RE: flipper44 #441910

Sounds good flipper44, will do, and enjoy your break...
icon url

muee88

02/07/22 11:45 PM

#442092 RE: flipper44 #441910

NWBO submitted a response on 2/2. The most recent rejection included several ancillary things needing to be taken care of. This looks like it will be allowed now, which is great!
icon url

pgsd

02/08/22 7:23 AM

#442116 RE: flipper44 #441910

Thanks Flipper, this is really interesting. In particular. the following:-

[b]Prior Rejections

"Applicant thanks the Examiner for withdrawal of rejection of Claims 1,3,10,11,12,18,19,20,22,29,30,31,33,34,48 and 50 under 35 U.S.C. 103 as being unpatentable over Fadul in view of Jacobs and Dulos as well as the rejection of Claims 1,3,6,10,11,12,18,20,22,25.29-31.33.48 and 50 under 35 103 as being unpatentable over Yamanaka in view of Jacobs and Dulos"

IMO this is a really positive development. What appears to have happened is NWBO has submitted new articles that have convinced the examiner they were wrong in saying the claims were "unpatentable" The fact that the examiner has withdrawn the rejection IMO is huge as they could easily have just stuck with the decision.

Also, two other claims (19 and 34) the examiner states "would be allowable" if rewritten "in independent form including all the limitations of the base claim and any intervening claims"
icon url

pgsd

02/08/22 8:02 AM

#442128 RE: flipper44 #441910

Similar process being undertaken with the European patent register (Examination in progress)

EP3065772 - COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

Latest entry:-

26.01.2022 New entry: Reply to examination report

https://register.epo.org/application?number=EP14859634&lng=en&tab=main